Eyal C. Attar insider trades

Open-market stock purchases and sales by Eyal C. Attar, CHIEF MEDICAL OFFICER at Vor Biopharma Inc, from SEC Form 4 filings since Oct 7, 2019.

Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -95%.

Recent trades

No open-market trades in the last 12 months.

Companies traded

  • VOR Vor Biopharma Inc: 4 sales, last Feb 13, 2025
  • APRE Aprea Therapeutics, Inc: 1 buy, 2 sales, last Jun 3, 2022

Get free alerts when Eyal C. Attar files a new trade →